A beneficial gut bacterium taken as a probiotic. Its most reliable effect is raising gut levels of beneficial Bifidobacterium, which fall with age. The clearest benefits are tied to specific strains: easing irritable bowel symptoms, reducing stress and improving sleep, and small metabolic gains in overweight people. Longevity claims rest on lab and animal work, still unproven. (Full Review)

Protocol

Standard Dose

10–20 billion CFU/day

Typical range 1–50 billion; higher counts not reliably more effective

Strain Selection

Match strain to goal

e.g. 35624 for IBS, 1714 for stress; multi-strain blends for general support

Timing

With or before a meal

Food buffers stomach acid; continued daily dosing required to maintain effects

Time to effect

Abundance & Digestion

Days to 2 weeks

Digestive and Bifidobacterium abundance changes

IBS Symptoms

4–8 weeks

Typical window for assessing symptom benefit

Metabolic Effects

Weeks to a few months

Where present, accrue with continued use

Benefits

High: Increases Bifidobacterium abundance and supports a beneficial gut microbiome

Medium: Relief of irritable bowel syndrome symptoms; metabolic improvements in body composition, blood sugar, and liver enzymes

Low: Reduced stress and improved cognitive markers; immune support and reduction of cold-like symptoms

Speculative: Longevity and anti-aging effects; improved mood and symptoms in neurological conditions

Contraindications

Significant immunosuppression (active chemotherapy, transplant recipients, advanced HIV)

Critical illness / intensive care

Central venous catheter

Premature infants

Short-bowel syndrome

Key Interactions

Antibiotics (amoxicillin, ciprofloxacin)

Antifungal and other antimicrobial agents

Prebiotic supplements (inulin, fructo-oligosaccharides, galacto-oligosaccharides)

Other probiotic supplements (Lactobacillus, other Bifidobacterium)

Risk & Side Effects

High: Transient digestive symptoms

Medium: Risk of invasive infection in immunocompromised or critically ill people

Low: Product contamination and mislabeling

Speculative: D-lactic acidosis and excessive fermentation; theoretical antibiotic resistance gene transfer

Monitoring

Marker	Target	Why
hs-CRP	< 1.0 mg/L	Tracks low-grade systemic inflammation that probiotics may reduce
Fasting glucose	70–90 mg/dL	Monitors metabolic benefit in those using it for metabolic goals
HbA1c	< 5.4%	Reflects average blood sugar over ~3 months
ALT	< 25 U/L (men), < 20 U/L (women)	Liver enzyme that may improve with probiotics in fatty liver
Stool microbiome panel (Bifidobacterium abundance)	Higher relative abundance	Confirms the supplement is shifting the microbiome as intended

Cadence: Recheck relevant markers after ~8–12 weeks of consistent use, then every 6–12 months if continued

Qualitative Assessment

Digestive comfort: frequency and consistency of bowel movements, bloating, and abdominal comfort
Energy and well-being: subjective energy levels and general sense of well-being
Stress and sleep: perceived stress and sleep quality, particularly relevant for stress-targeted strains
Regularity: stability of digestion during travel, dietary change, or after antibiotics

Bifidobacterium longum for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment